DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
50 hedge funds and large institutions have $352M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% more funds holding
Funds holding: 37 → 50 (+13)
Holders
50
Holding in Top 10
5
Calls
$2.28M
Puts
–
Top Buyers
| 1 | +$35M | |
| 2 | +$33M | |
| 3 | +$25.9M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$22.9M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.8M |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.9M | |
| 3 | -$397K | |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
-$190K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$166K |